Alpha Paradigm Partners, LLC Heron Therapeutics, Inc. Transaction History

Alpha Paradigm Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.63 - $9.94 $803,179 - $1.72 Million	-173,473 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $918,099 - $1.39 Million	109,952 Added 173.1%	173,473 $1.58 Billion
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $233,334 - $345,510	23,034 Added 56.89%	63,521 $679 Million
Q2 2021 Aug 13, 2021	BUY	$13.27 - $18.48 $537,262 - $748,199	40,487 New	40,487 $628 Million
Q1 2021 May 14, 2021	SELL	$14.49 - $20.72 $270,166 - $386,324	-18,645 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$14.61 - $22.14 $272,403 - $412,800	18,645 New	18,645 $395,000

178

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $186M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.